JP2013535979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535979A5 JP2013535979A5 JP2013525347A JP2013525347A JP2013535979A5 JP 2013535979 A5 JP2013535979 A5 JP 2013535979A5 JP 2013525347 A JP2013525347 A JP 2013525347A JP 2013525347 A JP2013525347 A JP 2013525347A JP 2013535979 A5 JP2013535979 A5 JP 2013535979A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- microrna
- micrornas
- cells
- panel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 37
- 108700011259 MicroRNAs Proteins 0.000 claims 32
- 239000002679 microRNA Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 15
- 238000002659 cell therapy Methods 0.000 claims 8
- 239000000356 contaminant Substances 0.000 claims 5
- 238000003556 assay Methods 0.000 claims 4
- 230000035899 viability Effects 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 238000012606 in vitro cell culture Methods 0.000 claims 2
- 239000003550 marker Substances 0.000 claims 2
- 238000001303 quality assessment method Methods 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 238000004113 cell culture Methods 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 1
- 238000013441 quality evaluation Methods 0.000 claims 1
- 210000001082 somatic cell Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1014049.9 | 2010-08-23 | ||
| GBGB1014049.9A GB201014049D0 (en) | 2010-08-23 | 2010-08-23 | Cell characterisation |
| PCT/GB2011/001241 WO2012025709A1 (en) | 2010-08-23 | 2011-08-19 | Cell characterisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535979A JP2013535979A (ja) | 2013-09-19 |
| JP2013535979A5 true JP2013535979A5 (enExample) | 2015-05-14 |
Family
ID=42984495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013525347A Pending JP2013535979A (ja) | 2010-08-23 | 2011-08-19 | 細胞特性評価 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20130196875A1 (enExample) |
| EP (1) | EP2609217B1 (enExample) |
| JP (1) | JP2013535979A (enExample) |
| KR (1) | KR20140006775A (enExample) |
| CN (1) | CN103403180A (enExample) |
| AU (1) | AU2011294936A1 (enExample) |
| BR (1) | BR112013004202A2 (enExample) |
| CA (1) | CA2847151C (enExample) |
| GB (1) | GB201014049D0 (enExample) |
| IL (1) | IL224888B (enExample) |
| SG (2) | SG10201506595QA (enExample) |
| WO (1) | WO2012025709A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2859119A2 (en) * | 2012-06-12 | 2015-04-15 | Institute for Systems Biology | Complex rna composition of bodily fluids |
| WO2017160880A1 (en) * | 2016-03-14 | 2017-09-21 | Aelan Cell Technologies, Inc. | Compositions and methods for the quality control of stem cell preparations |
| SG11201809902QA (en) | 2016-05-09 | 2018-12-28 | Sistemic Scotland Ltd | Functional prediction of cellular functions by means of microrna expression profiling in mesenchymal stem cells |
| JP6629770B2 (ja) * | 2017-01-19 | 2020-01-15 | シスメックス株式会社 | 細胞の分化状態を評価する方法 |
| JP6918062B2 (ja) * | 2017-01-19 | 2021-08-11 | シスメックス株式会社 | 細胞の分化状態を評価する方法 |
| GB2570404A (en) * | 2018-01-22 | 2019-07-24 | Sistemic Scotland Ltd | Cell contamination assay |
| WO2020072545A1 (en) * | 2018-10-01 | 2020-04-09 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | MicroRNA TRANSCRIPTIONAL SIGNATURE (miR-TS) EVALUATION OF STEM CELLS |
| CN113658636B (zh) * | 2021-07-22 | 2025-08-05 | 未来智人再生医学研究院(广州)有限公司 | 一种评估多能干细胞质量的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050123952A1 (en) * | 2003-09-04 | 2005-06-09 | Griffey Richard H. | Methods of rapid detection and identification of bioagents using microRNA |
| JP5697297B2 (ja) * | 2004-05-14 | 2015-04-08 | ロゼッタ ジノミクス リミテッド | マイクロｎａｓおよびその使用 |
| EP1966390A1 (en) * | 2005-12-29 | 2008-09-10 | Exiqon A/S | Detection of tissue origin of cancer |
| CN101316935B (zh) * | 2006-11-28 | 2012-02-29 | 博奥生物有限公司 | 一种用于诊断食道癌的芯片 |
| CN101622350A (zh) * | 2006-12-08 | 2010-01-06 | 奥斯瑞根公司 | 作为干预治疗靶标的miR-126调控基因和通路 |
| WO2008112283A2 (en) * | 2007-03-12 | 2008-09-18 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment |
| WO2009036332A1 (en) * | 2007-09-14 | 2009-03-19 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
| WO2009062503A1 (en) * | 2007-11-14 | 2009-05-22 | Dandrit Biotech A/S | Micro rnas as markers of the functional state of a dendritic cell |
| CA2717030A1 (en) * | 2008-02-28 | 2009-09-03 | The Ohio State University Research Foundation | Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof |
| US20100003674A1 (en) * | 2008-07-03 | 2010-01-07 | Cope Frederick O | Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions |
| WO2010082039A1 (en) * | 2009-01-19 | 2010-07-22 | Sistemic Scotland Limited | Methods employing non-coding rna expression assays |
-
2010
- 2010-08-23 GB GBGB1014049.9A patent/GB201014049D0/en not_active Ceased
-
2011
- 2011-08-19 SG SG10201506595QA patent/SG10201506595QA/en unknown
- 2011-08-19 US US13/818,750 patent/US20130196875A1/en not_active Abandoned
- 2011-08-19 JP JP2013525347A patent/JP2013535979A/ja active Pending
- 2011-08-19 BR BR112013004202A patent/BR112013004202A2/pt not_active IP Right Cessation
- 2011-08-19 WO PCT/GB2011/001241 patent/WO2012025709A1/en not_active Ceased
- 2011-08-19 CN CN2011800509567A patent/CN103403180A/zh active Pending
- 2011-08-19 AU AU2011294936A patent/AU2011294936A1/en not_active Abandoned
- 2011-08-19 SG SG2013038724A patent/SG190837A1/en unknown
- 2011-08-19 KR KR1020137007313A patent/KR20140006775A/ko not_active Ceased
- 2011-08-19 CA CA2847151A patent/CA2847151C/en active Active
- 2011-08-19 EP EP11760806.7A patent/EP2609217B1/en active Active
-
2013
- 2013-02-24 IL IL224888A patent/IL224888B/en active IP Right Grant
-
2016
- 2016-08-22 US US15/243,202 patent/US20170218446A1/en not_active Abandoned
-
2019
- 2019-08-26 US US16/551,337 patent/US20200080148A1/en not_active Abandoned
-
2022
- 2022-12-13 US US18/079,922 patent/US20230183803A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535979A5 (enExample) | ||
| Díaz-Díaz et al. | Pluripotency surveillance by Myc-driven competitive elimination of differentiating cells | |
| Bertolo et al. | An in vitro expansion score for tissue‐engineering applications with human bone marrow‐derived mesenchymal stem cells | |
| Burton et al. | Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo | |
| Jacobs et al. | Higher-density culture in human embryonic stem cells results in DNA damage and genome instability | |
| Chakraborty et al. | Combined RNAi and localization for functionally dissecting long noncoding RNAs | |
| Guo et al. | Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst | |
| BRPI0922572A2 (pt) | método para cultivar células pluripotentes, cultura de células de mamífero pluripotentes, meio de cultura de célula, célula animal pluripotente isolada, e, método para aumentar a pluripotência de uma célula de mamífero. | |
| CN103261407B (zh) | 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法 | |
| JP2016514950A5 (enExample) | ||
| GB2516196A8 (en) | Methods, compositions, kits, and systems for selective enrichment of target cells | |
| Briggs et al. | Single‐cell XIST expression in human preimplantation embryos and newly reprogrammed female induced pluripotent stem cells | |
| Cui et al. | Towards functional annotation of the preimplantation transcriptome: an RNAi screen in mammalian embryos | |
| WO2014200905A3 (en) | Early developmental genomic assay for characterizing pluripotent stem cell utility and safety | |
| Lai et al. | SOX10 ablation severely impairs the generation of postmigratory neural crest from human pluripotent stem cells | |
| WO2011103343A3 (en) | Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells | |
| Masala et al. | Methylation dynamics during folliculogenesis and early embryo development in sheep | |
| DeVeale et al. | Surfaceome profiling reveals regulators of neural stem cell function | |
| Dong et al. | Serum‐free culture system for spontaneous human mesenchymal stem cell spheroid formation | |
| WO2015003160A3 (en) | Hepatocytes in co-culture and uses thereof | |
| EP2644706A3 (en) | Method for evaluation of cultured cells, and method for screening of biomarker | |
| Harkness et al. | Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential | |
| Lacconi et al. | An improved in vitro model simulating the feto-maternal interface to study developmental effects of potentially toxic compounds: the example of titanium dioxide nanoparticles | |
| Krtolica et al. | Human embryonic stem cells as a model for embryotoxicity screening | |
| Zhuang et al. | Nephrocyte-neurocyte interaction and cellular metabolic analysis on membrane-integrated microfluidic device |